NEULASTA Side Effects

7023535-4 | Hypersensitivity, Pruritus, Rash, Urticaria
on Sep 22, 2010 Female patient from UNITED STATES , weighting 239.2 lb, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, pruritus, rash (What is rash?), urticaria. Neulasta dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

7019229-1 | Interstitial Lung Disease, Neutrophil Count Increased
Patient was taking Neulasta (View Usage). Patient had the following side effects: interstitial lung disease, neutrophil count increased on Sep 20, 2010 from BELGIUM Additional patient health information: Male patient , 57 years of age, . Neulasta dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINDESINE (View Vindesine Review and Vindesine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

7019210-2 | Lymphopenia
Adverse event was reported on Sep 21, 2010 by a Male patient taking Neulasta (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 78 years of age, After Neulasta was administered, patient had the following side effects: lymphopenia. During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

7019204-7 | C-reactive Protein Increased, Infection, Pyrexia
on Sep 21, 2010 Female patient from FINLAND , 59 years of age, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, infection (What is infection?), pyrexia. Neulasta dosage: . During the same period patient was treated with TOPOTECAN (View Topotecan Review and Topotecan Label ). Patient was hospitalized.


7019203-5 | C-reactive Protein Increased, Infection, Neutropenia, Pyrexia
on Sep 21, 2010 Female patient from FINLAND , 68 years of age, was treated with Neulasta (View Usage). Patient had the following side effects: c-reactive protein increased, infection (What is infection?), neutropenia, pyrexia. Neulasta dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), PARAPLATIN (View Paraplatin Review and Paraplatin Label ). Patient was hospitalized.

7016900-2 | Bradycardia, International Normalised Ratio Increased, Neutropenia, Renal Failure Acute, Urinary Tract Infection
Patient was taking Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: bradycardia, international normalised ratio increased, neutropenia, renal failure acute, urinary tract infection (What is urinary tract infection?) on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 152.1 lb, . Neulasta dosage: . During the same period patient was treated with ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENICAR (View Benicar Review and Benicar Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

7013905-2 | Erythema, Hypersensitivity, Oedema, Pruritus, Rash
Adverse event was reported on Sep 15, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: FRANCE , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: erythema, hypersensitivity, oedema, pruritus, rash (What is rash?). During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

7013099-3 | Febrile Neutropenia, Leukopenia
on Sep 14, 2010 Female patient from GERMANY , weighting 211.6 lb, was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia, leukopenia. Neulasta dosage: . During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

7013007-5 | Neutropenic Sepsis, Neutrophil Count Decreased
on Sep 17, 2010 Female patient from UNITED KINGDOM , weighting 185.2 lb, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: neutropenic sepsis, neutrophil count decreased. Neulasta dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

7009965-5 | Bronchopulmonary Aspergillosis, Granulomatous Liver Disease, Hepatic Fibrosis, Hepatic Lesion, Hepatic Necrosis, Lung Neoplasm, Neutropenia, Splenic Lesion, Systemic Candida
Patient was taking Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, granulomatous liver disease, hepatic fibrosis, hepatic lesion, hepatic necrosis, lung neoplasm, neutropenia, splenic lesion, systemic candida on Sep 16, 2010 from FRANCE Additional patient health information: Male patient , 75 years of age, . Neulasta dosage: . During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

7007607-6 | Asthenia, Fatigue, Feeling Abnormal, Malaise, Neutropenia, Pyrexia, White Blood Cell Count Decreased
Adverse event was reported on Sep 14, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: NETHERLANDS , weighting 187.4 lb, Patient had the following side effects: asthenia, fatigue, feeling abnormal, malaise, neutropenia, pyrexia, white blood cell count decreased. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), NEXIUM (View Nexium Review and Nexium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), EFFEXOR (View Effexor Review and Effexor Label ), LOPID (View Lopid Review and Lopid Label ), DYTENZIDE (View Dytenzide Review and Dytenzide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

7006465-3 | Pain, Somatoform Disorder
on Sep 14, 2010 Male patient from GERMANY , 50 years of age, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: pain (What is pain?), somatoform disorder. Neulasta dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), VINBLASTINE (View Vinblastine Review and Vinblastine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

6994667-1 | Febrile Neutropenia
on Sep 10, 2010 Female patient from UNITED STATES , 48 years of age, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Neulasta dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6994538-0 | Abdominal Pain, Spleen Scan Abnormal
Patient was taking Neulasta (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), spleen scan abnormal on Sep 10, 2010 from SLOVAKIA (Slovak Republic) Additional patient health information: Male patient , 31 years of age, . Neulasta dosage: . Patient was hospitalized.

6994534-3 | Abdominal Pain, Febrile Neutropenia, Lethargy, Myalgia, Nausea, Neutropenic Sepsis, Pyrexia
Adverse event was reported on Sep 10, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 138.9 lb, After Neulasta was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), febrile neutropenia, lethargy, myalgia, nausea (What is nausea?), neutropenic sepsis, pyrexia. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METFORMIN (View Metformin Review and Metformin Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), PIRITON (View Piriton Review and Piriton Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6994371-X | Bradycardia, Haemodialysis, International Normalised Ratio Increased, Neutropenia, Renal Failure Acute, Tumour Lysis Syndrome
on Sep 08, 2010 Male patient from UNITED STATES , 76 years of age, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, haemodialysis, international normalised ratio increased, neutropenia, renal failure acute, tumour lysis syndrome. Neulasta dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ), COUMADIN (View Coumadin Review and Coumadin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6993836-4 | Febrile Neutropenia
on Sep 07, 2010 Female patient from UNITED STATES , 56 years of age, was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia. Neulasta dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6989604-X | Febrile Neutropenia
Patient was taking Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: febrile neutropenia on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, . Neulasta dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6988890-X | Febrile Neutropenia, Salmonella Test Positive, Streptococcal Bacteraemia
Adverse event was reported on Sep 07, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: febrile neutropenia, salmonella test positive, streptococcal bacteraemia. During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6988887-X | Febrile Neutropenia, Legionella Test
on Sep 07, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia, legionella test. Neulasta dosage: . During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6988881-9 | Asthenia, Leukopenia, Malaise, Neutropenia, Thrombocytopenia
on Sep 07, 2010 Female patient from AUSTRALIA , weighting 96.12 lb, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: asthenia, leukopenia, malaise, neutropenia, thrombocytopenia. Neulasta dosage: . During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6982682-3 | Asthenia, Clostridium Difficile Colitis, Febrile Neutropenia, Salmonella Test Positive, Septic Shock, Streptococcal Bacteraemia
Patient was taking Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, clostridium difficile colitis, febrile neutropenia, salmonella test positive, septic shock, streptococcal bacteraemia on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 210.5 lb, . Neulasta dosage: . During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6973711-1 | Dyspnoea, Left Ventricular Dysfunction
Adverse event was reported on Sep 01, 2010 by a Male patient taking Neulasta (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 68 years of age, Patient had the following side effects: dyspnoea, left ventricular dysfunction. During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6973694-4 | Leukopenia, Neutropenia, Pyrexia
on Sep 02, 2010 Female patient from PORTUGAL , 66 years of age, weighting 114.6 lb, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: leukopenia, neutropenia, pyrexia. Neulasta dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ).

6973692-0 | Lymphopenia
on Sep 01, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: lymphopenia. Neulasta dosage: . During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6971834-4 | Febrile Neutropenia, Mucosal Inflammation, No Therapeutic Response
Patient was taking Neulasta (View Usage). Patient had the following side effects: febrile neutropenia, mucosal inflammation, no therapeutic response on Aug 30, 2010 from GERMANY Additional patient health information: Female patient , 74 years of age, . Neulasta dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6970991-3 | Guillain-barre Syndrome
Adverse event was reported on Aug 30, 2010 by a Male patient taking Neulasta (View Usage) (Dosage: ) . Location: GERMANY , 50 years of age, After Neulasta was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), VINBLASTINE (View Vinblastine Review and Vinblastine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

6969462-X | Lymphopenia
on Sep 01, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: lymphopenia. Neulasta dosage: . During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6968661-0 | Therapeutic Response Decreased, White Blood Cell Count Decreased
on Aug 30, 2010 Female patient from GERMANY , weighting 185.2 lb, was treated with Neulasta (View Usage). Patient had the following side effects: therapeutic response decreased, white blood cell count decreased. Neulasta dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), EMEND (View Emend Review and Emend Label ).

6968659-2 | Hyperglycaemia
Patient was taking Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: hyperglycaemia on Sep 03, 2010 from NETHERLANDS Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with lymphoma (What is lymphoma?) and. Neulasta dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ). Patient was hospitalized.

6966385-7 | Injury, Localised Infection, Mucosal Inflammation, Therapeutic Response Decreased
Adverse event was reported on Aug 26, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: AUSTRALIA , weighting 250.4 lb, Patient experienced the following unwanted or unexpected effects: injury, localised infection, mucosal inflammation, therapeutic response decreased. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), ENDONE (View Endone Review and Endone Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), NULYTELY (View Nulytely Review and Nulytely Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ). Patient was hospitalized.

6966384-5 | Febrile Neutropenia, Therapeutic Response Decreased
on Aug 26, 2010 Female patient from AUSTRALIA , weighting 146.6 lb, was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia, therapeutic response decreased. Neulasta dosage: . During the same period patient was treated with PLATINOL (View Platinol Review and Platinol Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6966383-3 | Fall, Febrile Neutropenia, Gastrointestinal Disorder, Therapeutic Response Decreased
on Aug 26, 2010 Female patient from AUSTRALIA , weighting 163.1 lb, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: fall (What is fall?), febrile neutropenia, gastrointestinal disorder, therapeutic response decreased. Neulasta dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METFORMIN (View Metformin Review and Metformin Label ), NORVASC (View Norvasc Review and Norvasc Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), EMEND (View Emend Review and Emend Label ). Patient was hospitalized.

6966380-8 | Febrile Neutropenia, Septic Shock
Patient was taking Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, septic shock on Aug 26, 2010 from CANADA Additional patient health information: Male patient , weighting 180.3 lb, . Neulasta dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXAN (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

6966307-9 | Anaphylactic Reaction, Chest Pain, Nausea, Rash Erythematous
Adverse event was reported on Aug 26, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: AUSTRALIA , 38 years of age, Patient had the following side effects: anaphylactic reaction, chest pain (What is chest pain?), nausea (What is nausea?), rash erythematous. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), MAXOLON (View Maxolon Review and Maxolon Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

6961792-0 | Hospitalisation
on Aug 23, 2010 Male patient from FRANCE , 68 years of age, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: hospitalisation. Neulasta dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ). Patient was hospitalized.

6961783-X | Anxiety, Back Pain, Insomnia, Panic Attack, Psychotic Disorder
on Aug 26, 2010 Male patient from AUSTRALIA , weighting 169.8 lb, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), back pain (What is back pain?), insomnia, panic attack, psychotic disorder (What is psychotic disorder?). Neulasta dosage: . During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), LIPITOR (View Lipitor Review and Lipitor Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6961560-X | Abscess, Blood Glucose Fluctuation, White Blood Cell Count Decreased
Patient was taking Neulasta (View Usage). Patient had the following side effects: abscess (What is abscess?), blood glucose fluctuation, white blood cell count decreased on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 255.3 lb, . Neulasta dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), METFORMIN (View Metformin Review and Metformin Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6956497-6 | Neutropenia, Therapeutic Response Decreased
Adverse event was reported on Aug 19, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: UNITED STATES , 64 years of age, weighting 143.1 lb, After Neulasta was administered, patient had the following side effects: neutropenia, therapeutic response decreased. During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), AVASTIN (View Avastin Review and Avastin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6956477-0 | Diarrhoea, Neutropenia
on Aug 20, 2010 Female patient from UNITED STATES , 48 years of age, weighting 156.5 lb, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, neutropenia. Neulasta dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6955411-7 | Febrile Neutropenia
on Aug 19, 2010 Female patient from UNITED STATES , weighting 105.2 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia. Neulasta dosage: . During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

6941636-3 | Lymphopenia
Patient was taking Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: lymphopenia on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, . Neulasta dosage: . During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ).

6941634-X | Lymphopenia
Adverse event was reported on Aug 17, 2010 by a Male patient taking Neulasta (View Usage) (Dosage: ) . Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: lymphopenia. During the same period patient was treated with IXEMPRA KIT (View Ixempra Kit Review and Ixempra Kit Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6941288-2 | Febrile Neutropenia, Salmonella Test Positive, Streptococcal Bacteraemia
on Aug 17, 2010 Female patient from UNITED STATES , weighting 210.5 lb, was treated with Neulasta (View Usage). Patient had the following side effects: febrile neutropenia, salmonella test positive, streptococcal bacteraemia. Neulasta dosage: . Patient was hospitalized.

6940856-1 | Hyperglycaemia
on Aug 19, 2010 Male patient from NETHERLANDS , weighting 169.8 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: hyperglycaemia. Neulasta dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TAVEGIL (View Tavegil Review and Tavegil Label ). Patient was hospitalized.

6937415-3 | Febrile Neutropenia, Legionella Test Positive
Patient was taking Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, legionella test positive on Aug 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 170.6 lb, . Neulasta dosage: . Patient was hospitalized.

6934528-7 | White Blood Cell Count Decreased
Adverse event was reported on Aug 12, 2010 by a Female patient taking Neulasta (View Usage) (Dosage: ) . Location: UNITED STATES , 80 years of age, Patient had the following side effects: white blood cell count decreased. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6934527-5 | Therapeutic Response Decreased, White Blood Cell Count Decreased
on Aug 12, 2010 Female patient from UNITED STATES , 47 years of age, was treated with Neulasta (View Usage). After Neulasta was administered, patient had the following side effects: therapeutic response decreased, white blood cell count decreased. Neulasta dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6928910-1 | Anaphylactic Reaction, Chest Pain, Nausea, Rash Erythematous
on Aug 09, 2010 Female patient from AUSTRALIA , 38 years of age, was treated with Neulasta (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, chest pain (What is chest pain?), nausea (What is nausea?), rash erythematous. Neulasta dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), MAXOLON (View Maxolon Review and Maxolon Label ). Patient was hospitalized.

6927828-8 | Hyperglycaemia
Patient was taking Neulasta (View Usage). Patient had the following side effects: hyperglycaemia on Aug 12, 2010 from NETHERLANDS Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with lymphoma (What is lymphoma?) and. Neulasta dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TAVEGIL (View Tavegil Review and Tavegil Label ). Patient was hospitalized.